AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11589259 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 393
Study 11589259 — intervention group
Group type: COMPARATOR
Intervention: Codeine 60 mg/acetaminophen 600 mg
Number of subjects: 393
Study 11589259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study 30801612 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast in the classroom with breakfast-specific nutrition education
Number of subjects: 1362
Study 30801612 — intervention group
Group type: COMPARATOR
Intervention: Control schools (breakfast before school in cafeteria and standard nutrition education)
Number of subjects: 1362
Study 29332743 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 minute rest interval (P1)
Number of subjects: 15
Study 29332743 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 minute rest interval (P3)
Number of subjects: 15
Study 29332743 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 minute rest interval (P5)
Number of subjects: 15
Study 27348762 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg/d)
Number of subjects: 210
Study 27348762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 25027230 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA SupremeTM, LMA Company, UK)
Number of subjects: 142
Study 25027230 — intervention group
Group type: COMPARATOR
Intervention: Face mask (control group)
Number of subjects: 142
Study 22210065 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported itch characteristics and validated scales for itch sensation, affect of itch, and severity.
Number of subjects: 23
Study 22210065 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported itch sensation dimensions.
Number of subjects: 23
Study 22210065 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of potential itch triggers and relief activities.
Number of subjects: 23
Study 20227681 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 538
Study 20227681 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 538
Study 20227681 — intervention group
Group type: EXPERIMENTAL
Intervention: Trajectory Group 2 (Amisulpride or Risperidone)
Number of subjects: 538
Study 20227681 — intervention group
Group type: EXPERIMENTAL
Intervention: Trajectory Group 4 (Amisulpride or Risperidone)
Number of subjects: 538
Study 17647145 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.15, 0.3, 0.6 U/kg)
Number of subjects: 12
Study 17647145 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 12
Study 17647145 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin (0.15, 0.3, 0.6 IU/kg)
Number of subjects: 12
Study 15596269 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical placement of laminaria
Number of subjects: 50
Study 15596269 — intervention group
Group type: COMPARATOR
Intervention: No laminaria
Number of subjects: 50
Study 15596269 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study 12163963 — intervention group
Group type: EXPERIMENTAL
Intervention: Massed practice (20 min) - Group A
Number of subjects: 41
Study 12163963 — intervention group
Group type: EXPERIMENTAL
Intervention: Distributed practice (20 min in 5 min blocks) - Group B
Number of subjects: 41
Study 12163963 — intervention group
Group type: COMPARATOR
Intervention: Distributed practice (15 min in 5 min blocks) - Group C
Number of subjects: 41
Study 10550081 — intervention group
Group type: COMPARATOR
Intervention: Insulin four times daily regimen
Number of subjects: 394
Study 10550081 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin twice daily regimen
Number of subjects: 394
Study 7607776 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual interview in the workplace
Number of subjects: 1200
Study 7607776 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-administered questionnaire in the workplace
Number of subjects: 1200
Study 7607776 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 1200
Study 7607776 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual interview off the worksite
Number of subjects: 1200
Study 7607776 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of self-report, urinalysis, and hair analysis
Number of subjects: 1200
Study 2254836 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin hydrochloride as an adjunct to scaling
Number of subjects: 9
Study 2254836 — intervention group
Group type: COMPARATOR
Intervention: Control site (quiescent)
Number of subjects: 9
Study 366087 — intervention group
Group type: EXPERIMENTAL
Intervention: Chymopapain intradiscally (chemonucleolysis)
Number of subjects: 66
Study 366087 — intervention group
Group type: COMPARATOR
Intervention: Placebo intradiscally
Number of subjects: 66
Study 31654818 — intervention group
Group type: EXPERIMENTAL
Intervention: hypercapnia (+9 Torr; 5% inspired CO2)
Number of subjects: 17
Study 31654818 — intervention group
Group type: COMPARATOR
Intervention: normocapnia (room air)
Number of subjects: 17
Study 31654818 — intervention group
Group type: COMPARATOR
Intervention: hypocapnia (−10 Torr; hyperventilation)
Number of subjects: 17
Study 29535054 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonbiologic simulator
Number of subjects: 41
Study 29535054 — intervention group
Group type: COMPARATOR
Intervention: Biologic wet lab
Number of subjects: 41
Study 26846356 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical steroids alone (Group A)
Number of subjects: 50
Study 26846356 — intervention group
Group type: COMPARATOR
Intervention: Topical and oral steroids (Group B)
Number of subjects: 50
Study 25307914 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal rinse
Number of subjects: 60
Study 25307914 — intervention group
Group type: COMPARATOR
Intervention: 0.2% Chlorhexidine digluconate
Number of subjects: 60
Study 25307914 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic rinse
Number of subjects: 60
Study 22591162 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers' use of sophisticated vocabulary and complex syntax
Number of subjects: 782
Study 22591162 — intervention group
Group type: COMPARATOR
Intervention: Teachers' total amount of talk
Number of subjects: 782
Study 20444859 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept + MTX
Number of subjects: 24
Study 20444859 — intervention group
Group type: COMPARATOR
Intervention: MTX
Number of subjects: 24
Study 17540689 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome present (n=1964/8397, 23.4%)
Number of subjects: 8397
Study 17540689 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal weight dysmetabolic subjects (with either diabetes or metabolic syndrome)
Number of subjects: 8397
Study 17540689 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight patients with dysmetabolic status
Number of subjects: 8397
Study 17540689 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients with dysmetabolic status
Number of subjects: 8397
Study 17540689 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome
Number of subjects: 8397
Study 16390756 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 38
Study 16390756 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 38
Study 11547219 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcomputer nutritional teaching games
Number of subjects: 1876
Study 11547219 — intervention group
Group type: COMPARATOR
Intervention: Conventional nutritional teaching
Number of subjects: 1876
Study 9691860 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% S(‐)‐bupivacaine
Number of subjects: 75
Study 9691860 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% S(‐)‐bupivacaine
Number of subjects: 75
Study 9691860 — intervention group
Group type: COMPARATOR
Intervention: 0.5% RS‐bupivacaine
Number of subjects: 75
Study 7871235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Injurious Behavior Inhibiting System (SIBIS)
Number of subjects: 1
Study 7871235 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief treatment sessions
Number of subjects: 1
Study 7871235 — intervention group
Group type: COMPARATOR
Intervention: Contingent shock
Number of subjects: 1
Study 2970498 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study 2970498 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 2970498 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lithium and imipramine
Number of subjects: 0
Study 31785189 — intervention group
Group type: COMPARATOR
Intervention: Normative Feedback Only (NFO)
Number of subjects: 5476
Study 31785189 — intervention group
Group type: COMPARATOR
Intervention: Consequences Feedback Only (CFO)
Number of subjects: 5476
Study 31785189 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Personalized Normative Feedback (PNF)
Number of subjects: 5476
Study 31075462 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrievable inferior vena cava (IVC) filter placement
Number of subjects: 3295
Study 31075462 — intervention group
Group type: COMPARATOR
Intervention: Control group (no filter placement)
Number of subjects: 3295
Study 31075462 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation therapy (without filter placement)
Number of subjects: 3295
Study 28320685 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800
Study 28320685 — intervention group
Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study 26493425 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (10 sessions of 90 minutes)
Number of subjects: 30
Study 26493425 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study 23872222 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine 120 mg/m(2) + Melphalan 100 mg/m(2) (FM100)
Number of subjects: 50
Study 23872222 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine 120 mg/m(2) + Melphalan 140 mg/m(2) (FM140)
Number of subjects: 50
Study 21876972 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D, n = 30)
Number of subjects: 60
Study 21876972 — intervention group
Group type: COMPARATOR
Intervention: Saline (group C, n = 30)
Number of subjects: 60
Study 19926042 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial approach
Number of subjects: 1024
Study 19926042 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral approach
Number of subjects: 1024
Study 16579891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol, 600 g
Number of subjects: 0
Study 12620438 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) 1 mg/NETA 0.5 mg
Number of subjects: 120
Study 12620438 — intervention group
Group type: EXPERIMENTAL
Intervention: E(2) 1 mg/NETA 0.25 mg
Number of subjects: 120
Study 12620438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 11144444 — intervention group
Group type: EXPERIMENTAL
Intervention: 3000 IU vitamin A and 5 IU vitamin E supplementation for 3 months
Number of subjects: 0
Study 11144444 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar viscosity and organoleptic characteristics)
Number of subjects: 0
Study 9080357 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance cardiography
Number of subjects: 20
Study 9080357 — intervention group
Group type: COMPARATOR
Intervention: Calibrated finger pulse pressure recordings (Portapres 2)
Number of subjects: 20
Study 8196848 — intervention group
Group type: EXPERIMENTAL
Intervention: SCMC‐Lys (750 mg/die in a linctus formula for 10 days and 2.7 g in a granular formula once a day for a maximum of 15 days)
Number of subjects: 70
Study 8196848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 3148381 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 45
Study 3148381 — intervention group
Group type: COMPARATOR
Intervention: Intensive subcutaneous insulin injections
Number of subjects: 45
Study 31862329 — intervention group
Group type: EXPERIMENTAL
Intervention: Advisory CDSS
Number of subjects: 16310
Study 29473351 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with low frequency (2 Hz) for 14 days
Number of subjects: 60
Study 29473351 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with high frequency (100 Hz) for 14 days
Number of subjects: 60
Study 26756390 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB (246Con)
Number of subjects: 1588
Study 26756390 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB (246Int)
Number of subjects: 1588
Study 26756390 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB (234Con)
Number of subjects: 1588
Study 26756390 — intervention group
Group type: COMPARATOR
Intervention: Control (4CMenB-naïve)
Number of subjects: 1588
Study 26756390 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB (all recipients)
Number of subjects: 1588
Study 24720694 — intervention group
Group type: COMPARATOR
Intervention: pdFIX (Immunine®)
Number of subjects: 44
Study 24720694 — intervention group
Group type: EXPERIMENTAL
Intervention: rFIX (Bax326)
Number of subjects: 44
Study 24720694 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Immunine® and Bax326
Number of subjects: 44
Study 23107831 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF)
Number of subjects: 217
Study 23107831 — intervention group
Group type: EXPERIMENTAL
Intervention: Support plus incentives
Number of subjects: 217
Study 23107831 — intervention group
Group type: EXPERIMENTAL
Intervention: Support alone
Number of subjects: 217
Study 23107831 — intervention group
Group type: COMPARATOR
Intervention: International support
Number of subjects: 217
Study 20205606 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy (SQT)
Number of subjects: 0
Study 20205606 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy (STT)
Number of subjects: 0
Study 25160919 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental support (provided by a friend)
Number of subjects: 100
Study 25160919 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a friend
Number of subjects: 100
Study 25160919 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental activation of a friend
Number of subjects: 100
Study 25160919 — intervention group
Group type: COMPARATOR
Intervention: Alone (no support)
Number of subjects: 100
Study 16605566 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-stroke subjects
Number of subjects: 0
Study 16605566 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study 11965271 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil 20 mg twice daily
Number of subjects: 5126
Study 11965271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5126
Study 9802528 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking frequency (number of days drinking)
Number of subjects: 569
Study 9802528 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking intensity (drinks per drinking day)
Number of subjects: 569
Study 8707437 — intervention group
Group type: EXPERIMENTAL
Intervention: Indium‐111 monoclonal antimyosin antibody imaging
Number of subjects: 10
Study 8707437 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up assessment of left ventricular function and antimyosin uptake
Number of subjects: 10
Study 8707437 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of left ventricular function
Number of subjects: 10
Study 2387950 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (1.558 g) and vitamin D (45 micrograms or 1,800 IU) administered daily for 11 weeks
Number of subjects: 139
Study 2387950 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 139
Study 64746 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 382
Study 64746 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 382
Study 64746 — intervention group
Group type: EXPERIMENTAL
Intervention: Xantinol nicotinate
Number of subjects: 382
Study 64746 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 382
Study 7325347 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg Buprenorphine (Temgesic)
Number of subjects: 0
Study 7325347 — intervention group
Group type: COMPARATOR
Intervention: 10 mg Nicomorphine (Vilan)
Number of subjects: 0
Study 30771856 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (folic acid [5 mg], B12 [0.4 mg], B6 [50 mg])
Number of subjects: 120
Study 30771856 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation
Number of subjects: 120
Study 30771856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 30541593 — intervention group
Group type: EXPERIMENTAL
Intervention: InBody S10-guided fluid management
Number of subjects: 244
Study 30541593 — intervention group
Group type: COMPARATOR
Intervention: Fluid management based only on clinical information
Number of subjects: 244
Study 27056131 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling plus self‐help materials
Number of subjects: 1173
Study 27056131 — intervention group
Group type: COMPARATOR
Intervention: Self‐help materials only
Number of subjects: 1173
Study 23890764 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study 23890764 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0
Study 23890764 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of naltrexone/disulfiram
Number of subjects: 0
Study 23890764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22362401 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) exercise
Number of subjects: 6
Study 22362401 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP) infusion
Number of subjects: 6
Study 19408641 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 90
Study 19408641 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with tramadol 100 mg
Number of subjects: 90
Study 19408641 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 90
Study 17983123 — intervention group
Group type: EXPERIMENTAL
Intervention: Centric occlusion
Number of subjects: 45
Study 17983123 — intervention group
Group type: EXPERIMENTAL
Intervention: Right eccentric mandibular position
Number of subjects: 45
Study 17983123 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel lift under the right foot
Number of subjects: 45
Study 16009749 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone methods for collecting survey data from churches
Number of subjects: 0
Study 16009749 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of telephone directories and religious sources
Number of subjects: 0
Study 16009749 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious sources alone
Number of subjects: 0
Study 11914248 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intracoronary beta-radiation
Number of subjects: 32
Study 11914248 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32
Study 9818750 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirome (2 g bd iv)
Number of subjects: 371
Study 9818750 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (2 g tds iv)
Number of subjects: 371
Study 9818750 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirome
Number of subjects: 371
Study 9818750 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 371
Study 7656523 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (1 mg)
Number of subjects: 324
Study 7656523 — intervention group
Group type: EXPERIMENTAL
Intervention: Buscopan (20 mg)
Number of subjects: 324
Study 7656523 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (placebo)
Number of subjects: 324
Study 2669003 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 27
Study 2669003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 798660 — intervention group
Group type: EXPERIMENTAL
Intervention: Dantrium
Number of subjects: 22
Study 798660 — intervention group
Group type: EXPERIMENTAL
Intervention: Valium
Number of subjects: 22
Study 798660 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Dantrium and Valium
Number of subjects: 22
Study 798660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 30225967 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (100 mg/d)
Number of subjects: 10
Study 29345864 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone alone
Number of subjects: 254
Study 29345864 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram and (blinded) naltrexone
Number of subjects: 254
Study 29345864 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram and (blinded) placebo
Number of subjects: 254
Study 29345864 — intervention group
Group type: COMPARATOR
Intervention: Placebo alone
Number of subjects: 254
Study 26033972 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-12/ACS group (0.015 mg/mL)
Number of subjects: 20
Study 26033972 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC) group
Number of subjects: 20
Study 23769170 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinsing the disposable tubing with normal saline and reinfusing it into the donor at the end of each plasma donation
Number of subjects: 45
Study 23769170 — intervention group
Group type: COMPARATOR
Intervention: Not rinsing the tubing system and not reinfusing normal saline
Number of subjects: 45
Study 21455339 — intervention group
Group type: EXPERIMENTAL
Intervention: Aethoxysklerol injection
Number of subjects: 107
Study 21455339 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclip hemostasis
Number of subjects: 107
Study 21455339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hemoclip hemostasis with aethoxysklerol injection
Number of subjects: 107
Study 18314118 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture for 25 minutes before and after embryo transfer
Number of subjects: 150
Study 18314118 — intervention group
Group type: COMPARATOR
Intervention: Control group (laid quietly)
Number of subjects: 150